依鲁替尼相关的玫瑰糠疹样皮疹。 - Suppr

Suppr

超能文献

Ibrutinib-associated pityriasis rosea-like rash.

作者信息

Bitar Carole, Sadeghian Azeen, Sullivan Lacey, Murina Andrea

机构信息

Department of Dermatology, Tulane University, New Orleans, Louisiana.

Department of Dermatopathology, Tulane University, New Orleans, Louisiana.

出版信息

JAAD Case Rep. 2017 Dec 19;4(1):55-57. doi: 10.1016/j.jdcr.2017.06.035. eCollection 2018 Jan.

DOI:10.1016/j.jdcr.2017.06.035

PMID:29387749

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5771723/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a6/5771723/26564ff6433c/gr1.jpg

相似文献

Ibrutinib-associated pityriasis rosea-like rash.

JAAD Case Rep. 2017 Dec 19;4(1):55-57. doi: 10.1016/j.jdcr.2017.06.035. eCollection 2018 Jan.

Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.

JAAD Int. 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Epub 2022 Feb 9.

Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?

JAAD Case Rep. 2018 Sep 14;4(8):800-801. doi: 10.1016/j.jdcr.2018.04.002. eCollection 2018 Sep.

Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™).

Ann Dermatol. 2011 Dec;23(Suppl 3):S360-3. doi: 10.5021/ad.2011.23.S3.S360. Epub 2011 Dec 27.

Pityriasis rosea like drug rash - a need to identify the disease in childhood.

J Clin Diagn Res. 2014 Aug;8(8):YD01-2. doi: 10.7860/JCDR/2014/8530.4652. Epub 2014 Aug 20.

Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.

Front Immunol. 2021 Nov 29;12:766272. doi: 10.3389/fimmu.2021.766272. eCollection 2021.

The pityriasis rosea calendar: a 7 year review of seasonal variation, age and sex distribution.

Nig Q J Hosp Med. 2010 Jan-Mar;20(1):29-31. doi: 10.4314/nqjhm.v20i1.57989.

Interventions for pityriasis rosea.

Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD005068. doi: 10.1002/14651858.CD005068.pub3.

Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia.

J Low Genit Tract Dis. 2013 Apr;17(2):226-9. doi: 10.1097/LGT.0b013e31825d7c5f.

Pityriasis rosea-like rash from captopril.

Arch Dermatol. 1982 Mar;118(3):186-7.

引用本文的文献

Pityriasis rosea-like drug eruption secondary to deucravacitinib.

JAAD Case Rep. 2024 Sep 1;53:63-65. doi: 10.1016/j.jdcr.2024.08.019. eCollection 2024 Nov.

Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell Malignancies.

Front Oncol. 2021 Oct 28;11:737943. doi: 10.3389/fonc.2021.737943. eCollection 2021.

Multifaceted Immunomodulatory Effects of the BTK Inhibitors Ibrutinib and Acalabrutinib on Different Immune Cell Subsets - Beyond B Lymphocytes.

Front Cell Dev Biol. 2021 Aug 13;9:727531. doi: 10.3389/fcell.2021.727531. eCollection 2021.

How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia.

Blood. 2019 Mar 21;133(12):1298-1307. doi: 10.1182/blood-2018-11-846808. Epub 2019 Jan 14.

Reply: Commentary on letter to the editor from Drago et al.

JAAD Case Rep. 2018 Sep 18;4(8):817. doi: 10.1016/j.jdcr.2018.04.001. eCollection 2018 Sep.

Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?

JAAD Case Rep. 2018 Sep 14;4(8):800-801. doi: 10.1016/j.jdcr.2018.04.002. eCollection 2018 Sep.

本文引用的文献

Ibrutinib-Associated Skin Toxicity: A Case of Maculopapular Rash in a 79-Year Old Caucasian Male Patient with Relapsed Waldenstrom's Macroglobulinemia and Review of the Literature.

Dermatol Reports. 2017 Apr 20;9(1):6976. doi: 10.4081/dr.2017.6976. eCollection 2017 Mar 13.

Ibrutinib-associated rash: a single-centre experience of clinicopathological features and management.

Br J Haematol. 2018 Jan;180(1):164-166. doi: 10.1111/bjh.14302. Epub 2016 Aug 18.

Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia.

JAMA Dermatol. 2016 Jun 1;152(6):698-701. doi: 10.1001/jamadermatol.2016.0225.

Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice.

PLoS One. 2015 Sep 8;10(9):e0137641. doi: 10.1371/journal.pone.0137641. eCollection 2015.

Ibrutinib in previously treated Waldenström's macroglobulinemia.

N Engl J Med. 2015 Apr 9;372(15):1430-40. doi: 10.1056/NEJMoa1501548.

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.

Lancet Oncol. 2015 Feb;16(2):169-76. doi: 10.1016/S1470-2045(14)71182-9. Epub 2014 Dec 31.

Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia.

Am J Hematol. 2015 Feb;90(2):179. doi: 10.1002/ajh.23775. Epub 2014 Jun 20.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.

N Engl J Med. 2013 Aug 8;369(6):507-16. doi: 10.1056/NEJMoa1306220. Epub 2013 Jun 19.

Novel Bruton's tyrosine kinase inhibitors currently in development.

Onco Targets Ther. 2013;6:161-76. doi: 10.2147/OTT.S33732. Epub 2013 Mar 6.

Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™).

Ann Dermatol. 2011 Dec;23(Suppl 3):S360-3. doi: 10.5021/ad.2011.23.S3.S360. Epub 2011 Dec 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Ibrutinib-associated pityriasis rosea-like rash.

JAAD Case Rep. 2017 Dec 19;4(1):55-57. doi: 10.1016/j.jdcr.2017.06.035. eCollection 2018 Jan.

Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.

JAAD Int. 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Epub 2022 Feb 9.

Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?

JAAD Case Rep. 2018 Sep 14;4(8):800-801. doi: 10.1016/j.jdcr.2018.04.002. eCollection 2018 Sep.

Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™).

Ann Dermatol. 2011 Dec;23(Suppl 3):S360-3. doi: 10.5021/ad.2011.23.S3.S360. Epub 2011 Dec 27.

Pityriasis rosea like drug rash - a need to identify the disease in childhood.

J Clin Diagn Res. 2014 Aug;8(8):YD01-2. doi: 10.7860/JCDR/2014/8530.4652. Epub 2014 Aug 20.

Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.

Front Immunol. 2021 Nov 29;12:766272. doi: 10.3389/fimmu.2021.766272. eCollection 2021.

The pityriasis rosea calendar: a 7 year review of seasonal variation, age and sex distribution.

Nig Q J Hosp Med. 2010 Jan-Mar;20(1):29-31. doi: 10.4314/nqjhm.v20i1.57989.

Interventions for pityriasis rosea.

Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD005068. doi: 10.1002/14651858.CD005068.pub3.

Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia.

J Low Genit Tract Dis. 2013 Apr;17(2):226-9. doi: 10.1097/LGT.0b013e31825d7c5f.

Pityriasis rosea-like rash from captopril.

Arch Dermatol. 1982 Mar;118(3):186-7.

引用本文的文献

Pityriasis rosea-like drug eruption secondary to deucravacitinib.

JAAD Case Rep. 2024 Sep 1;53:63-65. doi: 10.1016/j.jdcr.2024.08.019. eCollection 2024 Nov.

Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell Malignancies.

Front Oncol. 2021 Oct 28;11:737943. doi: 10.3389/fonc.2021.737943. eCollection 2021.

Multifaceted Immunomodulatory Effects of the BTK Inhibitors Ibrutinib and Acalabrutinib on Different Immune Cell Subsets - Beyond B Lymphocytes.

Front Cell Dev Biol. 2021 Aug 13;9:727531. doi: 10.3389/fcell.2021.727531. eCollection 2021.

How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia.

Blood. 2019 Mar 21;133(12):1298-1307. doi: 10.1182/blood-2018-11-846808. Epub 2019 Jan 14.

Reply: Commentary on letter to the editor from Drago et al.

JAAD Case Rep. 2018 Sep 18;4(8):817. doi: 10.1016/j.jdcr.2018.04.001. eCollection 2018 Sep.

Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?

JAAD Case Rep. 2018 Sep 14;4(8):800-801. doi: 10.1016/j.jdcr.2018.04.002. eCollection 2018 Sep.

本文引用的文献

Ibrutinib-Associated Skin Toxicity: A Case of Maculopapular Rash in a 79-Year Old Caucasian Male Patient with Relapsed Waldenstrom's Macroglobulinemia and Review of the Literature.

Dermatol Reports. 2017 Apr 20;9(1):6976. doi: 10.4081/dr.2017.6976. eCollection 2017 Mar 13.

Ibrutinib-associated rash: a single-centre experience of clinicopathological features and management.

Br J Haematol. 2018 Jan;180(1):164-166. doi: 10.1111/bjh.14302. Epub 2016 Aug 18.

Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia.

JAMA Dermatol. 2016 Jun 1;152(6):698-701. doi: 10.1001/jamadermatol.2016.0225.

Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice.

PLoS One. 2015 Sep 8;10(9):e0137641. doi: 10.1371/journal.pone.0137641. eCollection 2015.

Ibrutinib in previously treated Waldenström's macroglobulinemia.

N Engl J Med. 2015 Apr 9;372(15):1430-40. doi: 10.1056/NEJMoa1501548.

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.

Lancet Oncol. 2015 Feb;16(2):169-76. doi: 10.1016/S1470-2045(14)71182-9. Epub 2014 Dec 31.

Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia.

Am J Hematol. 2015 Feb;90(2):179. doi: 10.1002/ajh.23775. Epub 2014 Jun 20.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.

N Engl J Med. 2013 Aug 8;369(6):507-16. doi: 10.1056/NEJMoa1306220. Epub 2013 Jun 19.

Novel Bruton's tyrosine kinase inhibitors currently in development.

Onco Targets Ther. 2013;6:161-76. doi: 10.2147/OTT.S33732. Epub 2013 Mar 6.

Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™).

Ann Dermatol. 2011 Dec;23(Suppl 3):S360-3. doi: 10.5021/ad.2011.23.S3.S360. Epub 2011 Dec 27.